HK1148931A1 - Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin - Google Patents

Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin

Info

Publication number
HK1148931A1
HK1148931A1 HK11103212.3A HK11103212A HK1148931A1 HK 1148931 A1 HK1148931 A1 HK 1148931A1 HK 11103212 A HK11103212 A HK 11103212A HK 1148931 A1 HK1148931 A1 HK 1148931A1
Authority
HK
Hong Kong
Prior art keywords
drug
skin
core
bioerodible
polymer
Prior art date
Application number
HK11103212.3A
Other languages
English (en)
Chinese (zh)
Inventor
Kang-Jye Chou
Hong Guo
Paul Ashton
Robert W Shimizu
David A Watson
Original Assignee
Psivida Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/714,549 external-priority patent/US8871241B2/en
Application filed by Psivida Inc filed Critical Psivida Inc
Publication of HK1148931A1 publication Critical patent/HK1148931A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Prostheses (AREA)
HK11103212.3A 2003-11-13 2011-03-29 Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin HK1148931A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/714,549 US8871241B2 (en) 2002-05-07 2003-11-13 Injectable sustained release delivery devices
US54336804P 2004-02-09 2004-02-09

Publications (1)

Publication Number Publication Date
HK1148931A1 true HK1148931A1 (en) 2011-09-23

Family

ID=34636703

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103212.3A HK1148931A1 (en) 2003-11-13 2011-03-29 Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin

Country Status (20)

Country Link
EP (2) EP1696822B1 (de)
JP (3) JP5661226B2 (de)
AT (1) ATE460901T1 (de)
AU (1) AU2004292957C1 (de)
CA (1) CA2545650C (de)
CY (1) CY1114947T1 (de)
DE (1) DE602004026106D1 (de)
DK (1) DK1696822T3 (de)
ES (2) ES2340389T3 (de)
FR (1) FR14C0042I1 (de)
HK (1) HK1148931A1 (de)
IL (1) IL175584A (de)
MX (1) MXPA06005431A (de)
NO (1) NO20062362L (de)
NZ (3) NZ575950A (de)
PL (2) PL2233112T6 (de)
PT (2) PT1696822E (de)
SI (1) SI1696822T1 (de)
TW (2) TWI496597B (de)
WO (1) WO2005051234A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
ATE460901T1 (de) 2003-11-13 2010-04-15 Psivida Inc Injizierbares implantat mit verzögerter freisetzung mit einem bioerodierbaren matrixkern und einer bioerodierbaren haut
JP2008504938A (ja) 2004-07-02 2008-02-21 レイザー，エリオット 治療媒体送出装置およびその送出装置を用いて治療媒体を眼に送り出す方法
US20070149593A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
NZ595623A (en) 2006-03-31 2013-01-25 Mati Therapeutics Inc A drug insert surrounded by a sheath to expose a polymer containing a drug to surrounding tissues or an eye
UA97971C2 (ru) 2007-06-08 2012-04-10 Берингер Ингельхайм Интернациональ Гмбх Препарат невирапина пролонгированного высвобождения
JP5411140B2 (ja) 2007-09-07 2014-02-12 キュー エル ティー インク． 涙管インプラントの検出
FR2927798B1 (fr) * 2008-02-25 2011-03-04 C L Investissements Procede de fabrication d'un dispositif contraceptif intra-uterin et installation pour la mise en oeuvre de ce procede
US20100278895A1 (en) 2009-04-30 2010-11-04 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
JP2013515741A (ja) * 2009-12-23 2013-05-09 サイヴィーダ ユーエス，インコーポレイテッド 持続放出性送達デバイス
EP2555749B1 (de) * 2010-04-06 2016-10-26 Allergan, Inc. Retard-depotimplantate für intrakamerale wirkstofffreisetzung
AU2011256259A1 (en) 2010-05-17 2012-11-08 Novaer Holdings, Inc. Drug delivery devices for delivery of ocular therapeutic agents
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
CN103402582A (zh) * 2011-02-11 2013-11-20 普西维达公司 使用抗水肿疗法治疗黄斑水肿的方法
EP3290024B1 (de) 2011-08-29 2019-04-17 Mati Therapeutics Inc. Verzögerte freisetzung von wirkstoffen zur behandlung von glaukom oder okularer hypertonie
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
EP2750666B1 (de) 2011-08-30 2017-10-04 Universiteit Gent Mehrschichtige formulierungsfreisetzung
CA2866330A1 (en) * 2012-05-30 2013-12-05 Boston Scientific Scimed, Inc. Injectable biodegradable particles for controlled therapeutic agent release
CA2969171C (en) 2014-12-18 2023-12-12 Dsm Ip Assets B.V. Drug delivery system for delivery of acid sensitive drugs
WO2018231811A1 (en) * 2017-06-13 2018-12-20 EyePoint Pharmaceuticals, Inc. Bioerodible drug delivery devices
FR3085841B1 (fr) * 2018-09-14 2020-12-04 Oreal Procede de preparation de capsules et systeme associe
EP3698841A1 (de) * 2019-02-19 2020-08-26 L'oreal Injektionsvorrichtung
JP2023517987A (ja) * 2020-03-17 2023-04-27 アーロン エイチ． ブレイジー， 延長された薬物放出のための膨張可能なマルチ賦形剤の構造化された剤形

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6051576A (en) 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5550050A (en) * 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
US5486328A (en) 1994-05-31 1996-01-23 Randcastle Extrusion Systems, Inc. Extrusion surge suppressor and method
US5518672A (en) 1994-05-31 1996-05-21 Randcastle Extrusion Systems, Inc. Extrusion surge controller and method
US5569429A (en) 1995-05-05 1996-10-29 Randcastle Extrusion Systems, Inc. Dynamic seal and sealing method
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
SE0001893D0 (sv) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab Medical arrangement
JP2004535431A (ja) * 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
AU2002351739A1 (en) * 2001-12-18 2003-06-30 Novo Nordisk A/S Solid dose micro implant
ATE460901T1 (de) 2003-11-13 2010-04-15 Psivida Inc Injizierbares implantat mit verzögerter freisetzung mit einem bioerodierbaren matrixkern und einer bioerodierbaren haut

Also Published As

Publication number Publication date
PL1696822T3 (pl) 2010-08-31
DE602004026106D1 (de) 2010-04-29
NO20062362L (no) 2006-08-13
SI1696822T1 (sl) 2010-07-30
AU2004292957C1 (en) 2011-04-28
NZ575950A (en) 2010-06-25
PL2233112T6 (pl) 2014-11-28
PT1696822E (pt) 2010-04-28
TW200526285A (en) 2005-08-16
FR14C0042I1 (fr) 2014-06-27
WO2005051234A2 (en) 2005-06-09
TW201422269A (zh) 2014-06-16
ES2447816T7 (es) 2014-06-25
EP2233112A3 (de) 2011-03-02
JP2014040479A (ja) 2014-03-06
NZ581461A (en) 2011-04-29
NZ547619A (en) 2009-06-26
AU2004292957B2 (en) 2010-09-09
EP1696822B1 (de) 2010-03-17
MXPA06005431A (es) 2007-01-25
IL175584A0 (en) 2006-09-05
CA2545650C (en) 2015-08-18
JP2012072180A (ja) 2012-04-12
ES2340389T3 (es) 2010-06-02
ATE460901T1 (de) 2010-04-15
PL2233112T3 (pl) 2014-05-30
JP5918195B2 (ja) 2016-05-18
EP2233112B1 (de) 2013-11-20
EP2233112B3 (de) 2014-05-14
WO2005051234A3 (en) 2005-11-10
EP1696822A2 (de) 2006-09-06
TWI445559B (zh) 2014-07-21
CA2545650A1 (en) 2005-06-09
JP5661226B2 (ja) 2015-01-28
DK1696822T3 (da) 2010-05-17
ES2447816T3 (es) 2014-03-13
EP2233112A2 (de) 2010-09-29
PT2233112E (pt) 2014-02-27
AU2004292957A1 (en) 2005-06-09
IL175584A (en) 2015-05-31
TWI496597B (zh) 2015-08-21
JP2007512248A (ja) 2007-05-17
JP5526114B2 (ja) 2014-06-18
CY1114947T1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
HK1148931A1 (en) Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
Teoh et al. Fabricating scalable, personalized wound dressings with customizable drug loadings via 3D printing
AU651084B2 (en) Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
Johnson et al. Drug eluting implants in pharmaceutical development and clinical practice
DE60017956D1 (de) Biodegradierbare polymerzusammensetzung
ATE421316T1 (de) Herstellung von langzeit- arzneimittelabgabevorrichtungen mit polymeren auf polyurethanbasis
CA2575988A1 (en) Methods for manufacturing delivery devices and devices thereof
US20180326195A1 (en) Microneedle array and microneedle sheet
ES2093625T3 (es) Administracion extendida de farmaco de moleculas pequeñas solubles en agua.
FR2764514B1 (fr) Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
Masood Application of fused deposition modelling in controlled drug delivery devices
CN102264524A (zh) 模制套管与小深孔
JP2021506790A (ja) 塩形態の有効成分を含むマイクロニードルアレイ
PT1638534E (pt) Uso de etanol como plastificante para preparar implantes subcutâneos contendo princípios activos termolabiais dispersados numa matriz plga
IN2012DN04939A (de)
EP2558271A1 (de) Kanülenvorrichtung und verfahren und vorrichtung zum bestücken einer kanülenvorrichtung mit einem implantat
CY1114534T1 (el) Συσκευες ενεσιμης χορηγησης με παρατεταμενη αποδεσμευση
US20240277907A1 (en) Compositions of extended release coatings and methods for applying extended release coatings
CN1557501A (zh) 医用外科固定用绷带、指套及其制备方法
CN1209169C (zh) 医用外科固定材料及其制备方法
TW200500094A (en) Sustained release dosage forms of anesthetics for pain management